Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Mediwound ( (MDWD) ) has provided an update.
MediWound Ltd. announced the approval of its 2024 Share Incentive Plan at a special shareholder meeting. With 88% of the votes in favor, the plan involves rolling over 280,375 ordinary shares from the expiring 2014 Equity Incentive Plan, which is expected to enhance employee engagement and retention, potentially influencing the company’s market position positively.
More about Mediwound
MediWound Ltd. operates in the biotechnology industry, specializing in the development and commercialization of therapeutic products for tissue repair and regeneration. The company is headquartered in Yavne, Israel, and focuses primarily on innovative treatments for burns, chronic wounds, and other skin injuries.
YTD Price Performance: 69.12%
Average Trading Volume: 45,802
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $185.5M
Find detailed analytics on MDWD stock on TipRanks’ Stock Analysis page.
